115 related articles for article (PubMed ID: 31505164)
21. Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell.
Zhang X; Song Y; Wu Y; Dong Y; Lai L; Zhang J; Lu B; Dai F; He L; Liu M; Yi Z
Int J Cancer; 2011 Nov; 129(10):2502-11. PubMed ID: 21207415
[TBL] [Abstract][Full Text] [Related]
22. Malassezia-derived indoles activate the aryl hydrocarbon receptor and inhibit Toll-like receptor-induced maturation in monocyte-derived dendritic cells.
Vlachos C; Schulte BM; Magiatis P; Adema GJ; Gaitanis G
Br J Dermatol; 2012 Sep; 167(3):496-505. PubMed ID: 22533375
[TBL] [Abstract][Full Text] [Related]
23. A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway.
Xue H; Yuan G; Guo X; Liu Q; Zhang J; Gao X; Guo X; Xu S; Li T; Shao Q; Yan S; Li G
Autophagy; 2016 Jul; 12(7):1129-52. PubMed ID: 27163161
[TBL] [Abstract][Full Text] [Related]
24. Aryl hydrocarbon receptor response to indigoids in vitro and in vivo.
Peter Guengerich F; Martin MV; McCormick WA; Nguyen LP; Glover E; Bradfield CA
Arch Biochem Biophys; 2004 Mar; 423(2):309-16. PubMed ID: 15001395
[TBL] [Abstract][Full Text] [Related]
25. Indirubin Inhibits LPS-Induced Inflammation via TLR4 Abrogation Mediated by the NF-kB and MAPK Signaling Pathways.
Lai JL; Liu YH; Liu C; Qi MP; Liu RN; Zhu XF; Zhou QG; Chen YY; Guo AZ; Hu CM
Inflammation; 2017 Feb; 40(1):1-12. PubMed ID: 27718095
[TBL] [Abstract][Full Text] [Related]
26. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC
Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155
[TBL] [Abstract][Full Text] [Related]
27. The Role of Indirubins in Inflammation and Associated Tumorigenesis.
Cheng X; Merz KH
Adv Exp Med Biol; 2016; 929():269-290. PubMed ID: 27771929
[TBL] [Abstract][Full Text] [Related]
28. 7-Bromoindirubin-3'-oxime uncovers a serine protease-mediated paradigm of necrotic cell death.
Ribas J; Yuste VJ; Garrofé-Ochoa X; Meijer L; Esquerda JE; Boix J
Biochem Pharmacol; 2008 Jul; 76(1):39-52. PubMed ID: 18485331
[TBL] [Abstract][Full Text] [Related]
29. Indirubin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice through the inhibition of inflammation and the induction of Foxp3-expressing regulatory T cells.
Gao W; Guo Y; Wang C; Lin Y; Yu L; Sheng T; Wu Z; Gong Y
Acta Histochem; 2016 Jul; 118(6):606-614. PubMed ID: 27396532
[TBL] [Abstract][Full Text] [Related]
30. Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin.
Spink BC; Hussain MM; Katz BH; Eisele L; Spink DC
Biochem Pharmacol; 2003 Dec; 66(12):2313-21. PubMed ID: 14637189
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems.
Heshmati N; Cheng X; Dapat E; Sassene P; Eisenbrand G; Fricker G; Müllertz A
J Pharm Pharmacol; 2014 Nov; 66(11):1567-75. PubMed ID: 24961657
[TBL] [Abstract][Full Text] [Related]
32. Cell Death Induction by the Indirubin Derivative 7BIO and the BH3 Mimetic Drugs ABT-737 and GX15-070 in Medullary Thyroid Carcinoma Cells.
Broecker-Preuss M; Becher-Boveleth N; Mann K
Exp Clin Endocrinol Diabetes; 2016 May; 124(5):324-30. PubMed ID: 26849668
[TBL] [Abstract][Full Text] [Related]
33. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.
Ishida M; Mikami S; Shinojima T; Kosaka T; Mizuno R; Kikuchi E; Miyajima A; Okada Y; Oya M
Int J Cancer; 2015 Jul; 137(2):299-310. PubMed ID: 25523818
[TBL] [Abstract][Full Text] [Related]
34. 5-Nitro-5'-hydroxy-indirubin-3'-oxime (AGM130), an indirubin-3'-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo.
Ahn MY; Kim TH; Kwon SM; Yoon HE; Kim HS; Kim JI; Kim YC; Kang KW; Ahn SG; Yoon JH
Eur J Pharm Sci; 2015 Nov; 79():122-31. PubMed ID: 26342773
[TBL] [Abstract][Full Text] [Related]
35. Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK.
Zhen Y; Sørensen V; Jin Y; Suo Z; Wiedłocha A
Oncogene; 2007 Sep; 26(44):6372-85. PubMed ID: 17533378
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory Effects of Indirubin-3'-oxime Derivatives on Lipid Accumulation in 3T3-L1 Cells.
Nobushi Y; Saito H; Miyairi S; Uchiyama T; Kishikawa Y
Biol Pharm Bull; 2020; 43(3):503-508. PubMed ID: 32115509
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro.
Kim SH; Choi SJ; Kim YC; Kuh HJ
Arch Pharm Res; 2009 Jun; 32(6):915-22. PubMed ID: 19557370
[TBL] [Abstract][Full Text] [Related]
38. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
39. Aryl Hydrocarbon Receptor Promotes IL-10 Expression in Inflammatory Macrophages Through Src-STAT3 Signaling Pathway.
Zhu J; Luo L; Tian L; Yin S; Ma X; Cheng S; Tang W; Yu J; Ma W; Zhou X; Fan X; Yang X; Yan J; Xu X; Lv C; Liang H
Front Immunol; 2018; 9():2033. PubMed ID: 30283437
[TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory and antiviral effects of indirubin derivatives in influenza A (H5N1) virus infected primary human peripheral blood-derived macrophages and alveolar epithelial cells.
Mok CK; Kang SS; Chan RW; Yue PY; Mak NK; Poon LL; Wong RN; Peiris JS; Chan MC
Antiviral Res; 2014 Jun; 106():95-104. PubMed ID: 24717263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
